FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014817967> ?p ?o ?g. }

• W2014817967 abstract "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DCTumour initiation in the TH-MYCN transgenic mouse model of neuroblastoma is characterised by transient repression of p53 stress responses in embryonal ganglionic neuroblasts, causing them to persist postnatally as cancer-prone lesions 1, 2. p53 re-activation may be a potential therapeutic strategy for removal of these lesions before they later transform in response to oncogenic stimuli. One potential target for p53 activation is the FACT protein complex which is known to inhibit p53 signalling. Here we show that high mRNA expression levels of the two FACT subunits, SSRP1 and SPT16, in human primary neuroblastoma tissue were significantly associated with poor patient outcome (p<0.001) on Kaplan Meier analysis of 650 neuroblastoma patients. Both SSRP1 and SPT16 levels had a strong correlation with the level of MYCN expression, particularly in high risk MYCN-amplified neuroblastoma tissues (p<0.05). Inhibition of MYCN expression by a specific siRNA, lowered SSRP1 and SPT16 expression in two neuroblastoma tumor cell lines (BE(2)C and Kelly). Alamar blue assays revealed that a chemical inhibitor of FACT, Curaxin or CBL137, potently and selectively promoted cytotoxicity in neuroblastoma cell lines as compared to non-malignant MRC5 fibroblasts (p<0.001). To examine the role of FACT in MYCN-driven tumourigenesis we evaluated the effect of Curaxin on tumor initiation in TH-MYCN mice. Low micromolar Curaxin doses effectively restored normal in vitro, p53-dependent death responses to primary ganglion cells deprived of serum from neonatal TH-MYCN mice, while ganglion cultures from wild-type littermate mice were significantly more resistant to Curaxin treatment, with or without serum deprivation (p<0.001). Most importantly, prophylactic Curaxin treatment of 6 day old TH-MYCN mice had a marked inhibitory effect on postnatal ganglion neuroblast persistence in vivo for both hemizygote and homozygote TH-MYCN mice, as compared to vehicle-only treated animals (p=0.01, p=0.035, respectively). Taken together, our data for the first time identifies FACT as a novel effector of MYCN-driven neuroblastoma tumorigenesis. Inhibitors of the FACT complex may be a novel treatment for high risk MYCN-amplified neuroblastoma and a potential strategy for neuroblastoma prevention.1. Hansford, L. et al. Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification. Proceedings of the National Academy of Sciences of the United States of America 101, 12664-12669 (2004).2. Calao, M. et al. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation. Oncogene [ahead of print]Citation Format: Daniel R. Carter, Belamy B. Cheung, Tao Liu, Carol Au, Murray D. Norris, Michelle Haber, Jayne Murray, Katerina V. Gurova, Andrei V. Gudkov, Glenn M. Marshall. The facilitates chromatin transcription (FACT) protein complex promotes neuroblastoma tumor initiation. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 5043. doi:10.1158/1538-7445.AM2013-5043" @default.
• W2014817967 created "2016-06-24" @default.
• W2014817967 creator A5011765291 @default.
• W2014817967 creator A5013270397 @default.
• W2014817967 creator A5013297039 @default.
• W2014817967 creator A5015550222 @default.
• W2014817967 creator A5040415899 @default.
• W2014817967 creator A5069808553 @default.
• W2014817967 creator A5072009574 @default.
• W2014817967 creator A5078090612 @default.
• W2014817967 creator A5088108148 @default.
• W2014817967 creator A5088741070 @default.
• W2014817967 date "2013-04-15" @default.
• W2014817967 modified "2023-09-25" @default.
• W2014817967 title "Abstract 5043: The facilitates chromatin transcription (FACT) protein complex promotes neuroblastoma tumor initiation." @default.
• W2014817967 doi "https://doi.org/10.1158/1538-7445.am2013-5043" @default.
• W2014817967 hasPublicationYear "2013" @default.
• W2014817967 type Work @default.
• W2014817967 sameAs 2014817967 @default.
• W2014817967 citedByCount "0" @default.
• W2014817967 crossrefType "proceedings-article" @default.
• W2014817967 hasAuthorship W2014817967A5011765291 @default.
• W2014817967 hasAuthorship W2014817967A5013270397 @default.
• W2014817967 hasAuthorship W2014817967A5013297039 @default.
• W2014817967 hasAuthorship W2014817967A5015550222 @default.
• W2014817967 hasAuthorship W2014817967A5040415899 @default.
• W2014817967 hasAuthorship W2014817967A5069808553 @default.
• W2014817967 hasAuthorship W2014817967A5072009574 @default.
• W2014817967 hasAuthorship W2014817967A5078090612 @default.
• W2014817967 hasAuthorship W2014817967A5088108148 @default.
• W2014817967 hasAuthorship W2014817967A5088741070 @default.
• W2014817967 hasConcept C104317684 @default.
• W2014817967 hasConcept C2776715637 @default.
• W2014817967 hasConcept C502942594 @default.
• W2014817967 hasConcept C54355233 @default.
• W2014817967 hasConcept C71924100 @default.
• W2014817967 hasConcept C81885089 @default.
• W2014817967 hasConcept C83640560 @default.
• W2014817967 hasConcept C86803240 @default.
• W2014817967 hasConceptScore W2014817967C104317684 @default.
• W2014817967 hasConceptScore W2014817967C2776715637 @default.
• W2014817967 hasConceptScore W2014817967C502942594 @default.
• W2014817967 hasConceptScore W2014817967C54355233 @default.
• W2014817967 hasConceptScore W2014817967C71924100 @default.
• W2014817967 hasConceptScore W2014817967C81885089 @default.
• W2014817967 hasConceptScore W2014817967C83640560 @default.
• W2014817967 hasConceptScore W2014817967C86803240 @default.
• W2014817967 hasLocation W20148179671 @default.
• W2014817967 hasOpenAccess W2014817967 @default.
• W2014817967 hasPrimaryLocation W20148179671 @default.
• W2014817967 hasRelatedWork W1514316386 @default.
• W2014817967 hasRelatedWork W1565635645 @default.
• W2014817967 hasRelatedWork W1987246712 @default.
• W2014817967 hasRelatedWork W1988999672 @default.
• W2014817967 hasRelatedWork W2044059620 @default.
• W2014817967 hasRelatedWork W2070980120 @default.
• W2014817967 hasRelatedWork W2106480783 @default.
• W2014817967 hasRelatedWork W2114514966 @default.
• W2014817967 hasRelatedWork W2124292178 @default.
• W2014817967 hasRelatedWork W2242821001 @default.
• W2014817967 hasRelatedWork W2244412866 @default.
• W2014817967 hasRelatedWork W2315935406 @default.
• W2014817967 hasRelatedWork W2321676733 @default.
• W2014817967 hasRelatedWork W2333184775 @default.
• W2014817967 hasRelatedWork W2485760542 @default.
• W2014817967 hasRelatedWork W2493974458 @default.
• W2014817967 hasRelatedWork W2561204981 @default.
• W2014817967 hasRelatedWork W2561870970 @default.
• W2014817967 hasRelatedWork W2987081784 @default.
• W2014817967 hasRelatedWork W3187768808 @default.
• W2014817967 isParatext "false" @default.
• W2014817967 isRetracted "false" @default.
• W2014817967 magId "2014817967" @default.
• W2014817967 workType "article" @default.